These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
265 related articles for article (PubMed ID: 33336731)
1. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis. Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731 [TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA TRIM52-AS1 Sponges miR-514a-5p to Facilitate Hepatocellular Carcinoma Progression Through Increasing MRPS18A. Zhou C; Chen Z; Peng C; Chen C; Li H Cancer Biother Radiopharm; 2021 Mar; 36(2):211-219. PubMed ID: 32391716 [No Abstract] [Full Text] [Related]
3. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis. Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188 [TBL] [Abstract][Full Text] [Related]
4. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis. Huang C; Li K; Huang R; Zhu J; Yang J Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902 [TBL] [Abstract][Full Text] [Related]
5. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006 [TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis. Mu B; Lv C; Liu Q; Yang H J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA ZFPM2-AS1 regulates ITGB1 by miR-1226-3p to promote cell proliferation and invasion in hepatocellular carcinoma. Liu W; Zhang GQ; Zhu DY; Wang LJ; Li GT; Xu JG; Jin XL; Zhu YM; Yang XY Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7612-7620. PubMed ID: 32744687 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027 [TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA HAND2-AS1 reduced the viability of hepatocellular carcinoma via targeting microRNA-300/SOCS5 axis. Bi HQ; Li ZH; Zhang H Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):567-574. PubMed ID: 32224127 [TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA ASMTL-AS1 promotes hepatocellular carcinoma progression by sponging miR-1343-3p that suppresses LAMC1 (laminin subunit gamma 1). Mou Y; Sun Q Bioengineered; 2022 Jan; 13(1):746-758. PubMed ID: 34859735 [TBL] [Abstract][Full Text] [Related]
12. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis. Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264 [TBL] [Abstract][Full Text] [Related]
13. LncRNA DDX11-AS1 accelerates hepatocellular carcinoma progression via the miR-195-5p/MACC1 pathway. Wan T; Zheng J; Yao R; Yang S; Zheng W; Zhou P Ann Hepatol; 2021; 20():100258. PubMed ID: 32961346 [TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2. Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524 [TBL] [Abstract][Full Text] [Related]
15. ZSCAN16-AS1 expedites hepatocellular carcinoma progression via modulating the miR-181c-5p/SPAG9 axis to activate the JNK pathway. Liu J; Liu R; Liu Y; Li L; Cao H; Liu J; Cao G Cell Cycle; 2021 Jun; 20(12):1134-1146. PubMed ID: 34097562 [TBL] [Abstract][Full Text] [Related]
16. MAPKAPK5-AS1 drives the progression of hepatocellular carcinoma via regulating miR-429/ZEB1 axis. Peng Z; Ouyang X; Wang Y; Fan Q BMC Mol Cell Biol; 2022 Apr; 23(1):21. PubMed ID: 35468721 [TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Yao J; Yang Z; Yang J; Wang ZG; Zhang ZY Aging (Albany NY); 2021 May; 13(10):13726-13738. PubMed ID: 34023817 [TBL] [Abstract][Full Text] [Related]
18. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway. Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544 [TBL] [Abstract][Full Text] [Related]
19. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis. Fen H; Hongmin Z; Wei W; Chao Y; Yang Y; Bei L; Zhihua S Curr Pharm Des; 2020; 25(43):4630-4640. PubMed ID: 31692433 [TBL] [Abstract][Full Text] [Related]
20. LncRNA MAFG-AS1 regulates miR-125b-5p/SphK1 axis to promote the proliferation, migration, and invasion of bladder cancer cells. Tang C; Wu Y; Wang X; Chen K; Tang Z; Guo X Hum Cell; 2021 Mar; 34(2):588-597. PubMed ID: 33400245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]